The EMT signaling-related gene, LCN2, was up-regulated ∼21-fold in clinical specimens of cervical cancer, supporting our hypothesis that LCN2 modulates cervical cancer progression through the EMT pathway. Here, LCN2 is linked to cervical carcinoma.